The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bayer; Celgene; Lilly; Merck; Roche; Sanofi; SERVIER; Shire

Efficacy and safety of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600E–mutated biliary tract cancer (BTC): A cohort of the ROAR basket trial.
 
Zev A. Wainberg
Consulting or Advisory Role - Aduro Biotech; Array BioPharma; Bristol-Myers Squibb; Five Prime Therapeutics; Genentech; Lilly; Merck; Merck KGaA; Novartis; Sirtex Medical
Research Funding - Five Prime Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Genentech
 
Ulrik Niels Lassen
No Relationships to Disclose
 
Elena Elez
No Relationships to Disclose
 
Antoine Italiano
No Relationships to Disclose
 
Giuseppe Curigliano
Consulting or Advisory Role - Pfizer; Roche/Genentech
Speakers' Bureau - Novartis; Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Filippo G. De Braud
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Dompè; Ignyta; Novartis; Pfizer; SERVIER; Tiziana Life Sciences
Speakers' Bureau - Bristol-Myers Squibb; Lilly; Menarini; MSD; Novartis; Pfizer; Roche; SERVIER
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Ignyta (Inst); Lilly (Inst); MedImmune (Inst); Merck Serono (Inst); MSD (Inst); Nektar; Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche
 
Gerald Prager
No Relationships to Disclose
 
Richard Greil
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Janssen; Merck; Merck Sharp & Dohme; Novartis; Roche; Sandoz; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Roche; Takeda
Research Funding - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Merck; Merck Sharp & Dohme; Novartis; Roche; Sandoz; Takeda
 
Alexander Stein
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck KGaA; MSD; Roche
Speakers' Bureau - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Lilly; Merck KGaA; Roche; Sanofi; Servier
Research Funding - Bristol-Myers Squibb (Inst); Merck KGaA (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Angelica Fasolo
No Relationships to Disclose
 
Jan H. M. Schellens
Employment - Modra Pharmaceuticals
Stock and Other Ownership Interests - Modra Pharmaceuticals
Research Funding - Dutch Cancer Society (Inst)
 
Patrick Y. Wen
Honoraria - Abbvie; AstraZeneca; Genentech/Roche; Immunomic Therapeutics; Kazia Therapeutics; Lilly; Puma Biotechnology; Vascular Biogenics; VBI Vaccines; ZIOPHARM Oncology
Consulting or Advisory Role - Abbvie; AstraZeneca; Genentech/Roche; Immunomic Therapeutics; Kazia Therapeutics; Lilly; Puma Biotechnology; Vascular Biogenics; VBI Vaccines; ZIOPHARM Oncology
Speakers' Bureau - Merck
Research Funding - Abbvie; Agios; AstraZeneca; BeiGene; Genentech/Roche; Kazia Therapeutics; Merck; Novartis; Oncoceutics; VBI Vaccines
 
Aislyn D. Boran
Employment - Novartis
 
Paul Burgess
Employment - Novartis
 
Vivek Subbiah
Consulting or Advisory Role - MedImmune
Research Funding - Abbvie (Inst); Agensys (Inst); Alfasigma (Inst); Amgen (Inst); Bayer (Inst); Berg Pharma (Inst); Blueprint Medicines (Inst); Boston Biomedical (Inst); D3 Oncology Solutions (Inst); Exelixis (Inst); Fujifilm (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Idera (Inst); Incyte (Inst); Inhibrx (Inst); LOXO (Inst); Multivir (Inst); NanoCarrier (Inst); Northwest Biotherapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Takeda (Inst); Vegenics (Inst)
Travel, Accommodations, Expenses - Bayer; PharmaMar